CapitalG returned for a late-stage round that pushed Collibra’s total funding beyond $345m and boosted its valuation to $2.3bn.

The Parkinson's disease therapy developer closed the series A funding less than four months after a Eurofarma-backed seed round.

The enterprise communication platform developer has now raised more than $62m altogether, Dell Technologies Capital leading its latest round.

Born out of the Stanford Virtual Human Interaction Lab, Strivr uses virtual reality to train athletes and employees and has now collected $51m in funding altogether.

Based on research at Grousbeck Gene Therapy Center and Massachusetts Eye and Ear, Affinia has raised $60m in a series A round to advance its gene therapies into the clinic.

Galijasevic predicts collaborations among corporate VCs and startups will only accelerate as they look to innovative technologies to address customer needs during tumultuous times.

Early investors and employees were set to benefit from a $3bn tender offer for the troubled workspace provider but key investor SoftBank has pulled out.

Lonza participated in the gene therapy developer's series A round alongside Partners Innovation Fund, having also licensed technology to the startup.

General Catalyst led a $51m round for the Ascension-backed healthcare automation technology developer, which has now received $119m in total.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.